Your browser doesn't support javascript.
Metabolic syndrome and risk of COVID-19-related hospitalization: a large, population-based cohort study carried out during the first European outbreak of SARS-CoV-2 infection in the Metropolitan area of Milan (Lombardy Region, Northern Italy).
Gervasi, Federico; Andreano, Anita; Russo, Antonio Giampiero.
  • Gervasi F; UOC Epidemiology Unit, Agency for Health Protection of the Metropolitan Area of Milan (Italy).
  • Andreano A; UOC Epidemiology Unit, Agency for Health Protection of the Metropolitan Area of Milan (Italy).
  • Russo AG; UOC Epidemiology Unit, Agency for Health Protection of the Metropolitan Area of Milan (Italy); agrusso@ats-milano.it.
Epidemiol Prev ; 45(6): 477-485, 2021.
Article in English | MEDLINE | ID: covidwho-1605000
ABSTRACT

BACKGROUND:

since the beginning of the COVID-19 pandemic, specific characteristics of the infected subjects appeared to be associated with a severe disease, leading to hospitalization or death.

OBJECTIVES:

to evaluate the association between three components of the metabolic syndrome (diabetes mellitus, dyslipidaemia, and hypertension), alone and in combination, and risk of hospitalization in subjects with nasopharyngeal swab-confirmed COVID-19.

DESIGN:

cohort study. SETTING AND

PARTICIPANTS:

the study subjects were all COVID-19 cases diagnosed in the area of the Agency for Health Protection of the Metropolitan Area of Milan (Lombardy Region, Northern Italy) between 10.02.2020 and 25.04.2020, whose data were gathered with an ad hoc information system developed at the beginning of the pandemic. MAIN OUTCOME

MEASURES:

the association between metabolic syndrome components (alone and in combination) and hospitalization (both in any ward and in intensive care unit) was measured by means of cause-specific Cox models with gender, age, and comorbidities as potential confounders.

RESULTS:

the cohort included 15,162 subjects followed from diagnosis up to 20.07.2020. Adjusted hazard ratios (HRs) of hospitalization in any ward estimated by the Cox model were 1.26 for uncomplicated diabetes mellitus (95%CI 1.18-1.34); 1.21 for complicated diabetes mellitus (95%CI 1.05-1.39); 1.07 for dyslipidaemia (95%CI 1.00-1.14); and 1.11 for hypertension (95%CI 1.05-1.17). When all components coexisted in the same subject, the HR was 1.46 (95%CI 1.31-1.62). A significant increase in risk of hospitalization in intensive care unit was found for uncomplicated diabetes mellitus (HR 1.38; 95%CI 1.15-1.66).

CONCLUSIONS:

this population-based study confirms that metabolic syndrome components increase the risk of hospitalization for COVID-19. The HR increases in an additive manner when the three components are simultaneously present.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Metabolic Syndrome / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Limits: Humans Country/Region as subject: Europa Language: English Journal: Epidemiol Prev Journal subject: Epidemiology Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Metabolic Syndrome / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Limits: Humans Country/Region as subject: Europa Language: English Journal: Epidemiol Prev Journal subject: Epidemiology Year: 2021 Document Type: Article